Skip to content
Screener

Beta Bionics BBNX Price / sales

Price / sales at other companies

Insulet logo
InsuletPODD
3.5×-5.8×
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
1×-0.3×
Medtronic logo
MedtronicMDT
2.9×-0.4×
Embecta Corp. logo
Embecta Corp.EMBC
0.2×-0.4×
AdaptHealth logo
AdaptHealthAHCO
0.5×0.0×
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
5.6×-0.1×

Other financials

Income statement

See full
Revenue$32.0M+37.8%
Gross profit$18.9M+51.2%
Operating income-$25.6M-28.7%
Net income-$23.4M-38.7%
EPS (diluted)-$0.53-35.9%

Balance sheet

See full
Cash & equivalents$44.3M+26.4%
Total debt$6.5M-2.6%
Total equity$256.4M-15.0%
Total assets$292.4M-11.4%

Cash flow

See full
Operating cash flow-$14.6M-7.6%
CapEx$1.0M-41.6%
Free cash flow-$15.7M-1.9%

Valuation

See full
Market cap$715.34M+15.1%
Enterprise value$677.53M+14.2%

Profitability

See full
Gross margin58.3%+4.4pp
Operating margin-69.8%-8.0pp
Net margin-61.3%-15.8pp
FCF margin-51.6%-13.4pp

Returns & leverage

See full
Return on equity-26.2%—
Debt / equity0×0.0×
Current ratio8.9×-5.8×

Where this comes from

Calculated from Beta Bionics’s reported figures.

market cap/total revenue=5.9×

Based on the most recent quarter.

The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323777

FAQ

What is Beta Bionics's price / sales?
Beta Bionics (BBNX) reported price / sales of 5.9× in Q2 2026.
How has Beta Bionics's price / sales changed year-over-year?
Beta Bionics's price / sales decreased by 32.8% year-over-year, from 8.7× to 5.9×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Ask your AI about Beta Bionics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude